Chief Business Officers: Shedding Light on Biotech’s Dealmakers
Stephanie Bewick, Chief Business Officer at Destiny Pharma outlines her experiences of how a CBO maximises their company’s commercial appeal and lands deals in the biotech industry…
Tag Archive for: Pharma
Destiny Pharma appoints Dr Yuri Martina as CMO
Destiny Pharma strengthens Executive Management Team with the appointment of Dr Yuri Martina as Chief Medical Officer Brighton, United Kingdom – 3rd May 2022 – Destiny Pharma plc (AIM:DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today announces the appointment of Dr. Yuri Martina as Chief Medical Officer (CMO). Read more
Sachs Associates Healthcare Events 2022
As a supporter of Sachs Associates, Optimum is pleased to be able to offer a 10% discount on its brilliant events coming up in 2022.
Novo Seeds Provides Business Update on a Record Year – Building Exceptional Companies for Global Impact
Over US$ 550 million raised by portfolio companies in 2021 IO Biotech IPO on US NASDAQ Forendo Pharma acquired for nearly US$ 1 billion Muna launched with world-leading science to advance latest scientific breakthroughs in neuroscience Adcendo raised US$ 60 million Series A to deliver next-generation Antibody-Drug Conjugates Hemab raised US$ 50 million Series A to […]
2021 and beyond with Destiny Pharma’s CEO, Neil Clark & CFO Shaun Claydon
Management of Destiny Pharma (DEST), the AIM listed infection prevention biotechnology company, offer an overview of the Company, their platform and their late stage clinical assets heading towards phase 3 trails. The team expand on the anti infective market, their COVID 19 program and the strength of their balance sheet. The Company finish with their […]
